Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.

To assess the feasibility and effectiveness of quantitative intravoxel incoherent motion (IVIM) of Diffusion-weighted imaging (DWI) in the assessment of liver metastases treated with targeted chemotherapy agents.12 patients with unresectable liver metastases from colorectal cancer were enrolled and...

Full description

Bibliographic Details
Main Authors: Vincenza Granata, Roberta Fusco, Orlando Catalano, Salvatore Filice, Daniela Maria Amato, Guglielmo Nasti, Antonio Avallone, Francesco Izzo, Antonella Petrillo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4643930?pdf=render
_version_ 1818293637910364160
author Vincenza Granata
Roberta Fusco
Orlando Catalano
Salvatore Filice
Daniela Maria Amato
Guglielmo Nasti
Antonio Avallone
Francesco Izzo
Antonella Petrillo
author_facet Vincenza Granata
Roberta Fusco
Orlando Catalano
Salvatore Filice
Daniela Maria Amato
Guglielmo Nasti
Antonio Avallone
Francesco Izzo
Antonella Petrillo
author_sort Vincenza Granata
collection DOAJ
description To assess the feasibility and effectiveness of quantitative intravoxel incoherent motion (IVIM) of Diffusion-weighted imaging (DWI) in the assessment of liver metastases treated with targeted chemotherapy agents.12 patients with unresectable liver metastases from colorectal cancer were enrolled and received neoadjuvant FOLFIRI (5-fluorouracil, leucovorin, irinotecan) plus bevacizumab therapy. DWI was performed for 36 metastases at baseline and after 14 days from starting the treatment. In addition to the basic IVIM metrics, the product between pseudo-diffusivity and perfusion fraction was considered as a descriptor roughly analogous to the flow. Median diffusion parameters of Region of Interest (ROI) were used as representative values for each lesion. Normalized parameters in comparison with the median value of spleen were also collected. The percentual change of the diffusion parameters was calculated. The response to chemotherapy was evaluated according the Response Evaluation Criteria in Solid Tumors (RECIST) as calculated on whole-body CT scan obtained three months after treatment. Mann Whitney test and Receiver operating characteristic (ROC) analysis were performed.24 lesions were categorized as responding and 12 as not responding. There was no statistically significant difference among absolute and normalized diffusion parameters between the pretreatment and the post-treatment findings. Instead, the perfusion fraction (fp) values showed a statistical difference between responder and non-responder lesions: sensitivity and specificity of fp variation was 62% and 93%, respectively.IVIM parameters represent a valuable tool in the evaluation of the anti-angiogenic therapy in patients with liver metastases from colorectal cancer. A percentage change of fp represents the most effective DWI marker in the assessment of tumor response.
first_indexed 2024-12-13T03:19:02Z
format Article
id doaj.art-2c71e4e2d0054d51bc5e77b03915ecea
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T03:19:02Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2c71e4e2d0054d51bc5e77b03915ecea2022-12-22T00:01:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014287610.1371/journal.pone.0142876Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.Vincenza GranataRoberta FuscoOrlando CatalanoSalvatore FiliceDaniela Maria AmatoGuglielmo NastiAntonio AvalloneFrancesco IzzoAntonella PetrilloTo assess the feasibility and effectiveness of quantitative intravoxel incoherent motion (IVIM) of Diffusion-weighted imaging (DWI) in the assessment of liver metastases treated with targeted chemotherapy agents.12 patients with unresectable liver metastases from colorectal cancer were enrolled and received neoadjuvant FOLFIRI (5-fluorouracil, leucovorin, irinotecan) plus bevacizumab therapy. DWI was performed for 36 metastases at baseline and after 14 days from starting the treatment. In addition to the basic IVIM metrics, the product between pseudo-diffusivity and perfusion fraction was considered as a descriptor roughly analogous to the flow. Median diffusion parameters of Region of Interest (ROI) were used as representative values for each lesion. Normalized parameters in comparison with the median value of spleen were also collected. The percentual change of the diffusion parameters was calculated. The response to chemotherapy was evaluated according the Response Evaluation Criteria in Solid Tumors (RECIST) as calculated on whole-body CT scan obtained three months after treatment. Mann Whitney test and Receiver operating characteristic (ROC) analysis were performed.24 lesions were categorized as responding and 12 as not responding. There was no statistically significant difference among absolute and normalized diffusion parameters between the pretreatment and the post-treatment findings. Instead, the perfusion fraction (fp) values showed a statistical difference between responder and non-responder lesions: sensitivity and specificity of fp variation was 62% and 93%, respectively.IVIM parameters represent a valuable tool in the evaluation of the anti-angiogenic therapy in patients with liver metastases from colorectal cancer. A percentage change of fp represents the most effective DWI marker in the assessment of tumor response.http://europepmc.org/articles/PMC4643930?pdf=render
spellingShingle Vincenza Granata
Roberta Fusco
Orlando Catalano
Salvatore Filice
Daniela Maria Amato
Guglielmo Nasti
Antonio Avallone
Francesco Izzo
Antonella Petrillo
Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
PLoS ONE
title Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
title_full Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
title_fullStr Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
title_full_unstemmed Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
title_short Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
title_sort early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs the role of intravoxel incoherent motion in diffusion weighted imaging
url http://europepmc.org/articles/PMC4643930?pdf=render
work_keys_str_mv AT vincenzagranata earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT robertafusco earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT orlandocatalano earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT salvatorefilice earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT danielamariaamato earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT guglielmonasti earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT antonioavallone earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT francescoizzo earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging
AT antonellapetrillo earlyassessmentofcolorectalcancerpatientswithlivermetastasestreatedwithantiangiogenicdrugstheroleofintravoxelincoherentmotionindiffusionweightedimaging